Oncolytics Biotech ( TSE:ONC – Get Rating ) received a C$9.00 target price from Cantor Fitzgerald in a research note issued to investors on Monday, BayStreet.CA reports. The firm currently has an 'overweight' rating on the stock. Cantor Fitzgerald's price objective suggests a potential upside of 320.56% from the company's current price. Oncolytics Biotech Trading Down 1.8 % Shares of TSE:ONC traded down C$0.04 during midday trading on Monday, hitting C$2.14. The company had a trading volume of 14,044 shares, compared to its average volume of 44,499.

https://www.dailypolitical.com/2023/03/06/oncolytics-biotech-tseonc-pt-set-at-c9-00-by-cantor-fitzgerald.html

#dailypolitical